Entering text into the input field will update the search result below

Protagonist Therapeutics slumps 7.5% on raising $100M via public offering

  • Protagonist Therapeutics (NASDAQ:PTGX) commences $100M public offering of shares.
  • Underwriter's 30-day option to purchase up to an additional 15% shares.
  • Shares drop 7.5% during after market hours.
  • Press Release

Recommended For You

More Trending News

About PTGX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PTGX--
Protagonist Therapeutics, Inc.